Co-Authors
This is a "connection" page, showing publications co-authored by Gennaro Ciliberto and Giulia Piaggio.
Connection Strength
0.712
-
Early Onset of SARS-COV-2 Antibodies after First Dose of BNT162b2: Correlation with Age, Gender and BMI. Vaccines (Basel). 2021 Jun 22; 9(7).
Score: 0.238
-
Initial observations on age, gender, BMI and hypertension in antibody responses to SARS-CoV-2 BNT162b2 vaccine. EClinicalMedicine. 2021 Jun; 36:100928.
Score: 0.237
-
Lower response to BNT162b2 vaccine in patients with myelofibrosis compared to polycythemia vera and essential thrombocythemia. J Hematol Oncol. 2021 07 29; 14(1):119.
Score: 0.060
-
H-Ras gene takes part to the host immune response to COVID-19. Cell Death Discov. 2021 Jun 25; 7(1):158.
Score: 0.060
-
Fifth-week immunogenicity and safety of anti-SARS-CoV-2 BNT162b2 vaccine in patients with multiple myeloma and myeloproliferative malignancies on active treatment: preliminary data from a single institution. J Hematol Oncol. 2021 05 17; 14(1):81.
Score: 0.059
-
Gene signature and immune cell profiling by high-dimensional, single-cell analysis in COVID-19 patients, presenting Low T3 syndrome and coexistent hematological malignancies. J Transl Med. 2021 04 01; 19(1):139.
Score: 0.059